Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247764.RACmYtj_y2LJGU4zwtuFCh_bKO2aoyK973Apte2EyuaV0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247764.RACmYtj_y2LJGU4zwtuFCh_bKO2aoyK973Apte2EyuaV0130_assertion type Assertion NP1247764.RACmYtj_y2LJGU4zwtuFCh_bKO2aoyK973Apte2EyuaV0130_head.
- NP1247764.RACmYtj_y2LJGU4zwtuFCh_bKO2aoyK973Apte2EyuaV0130_assertion description "[This novel role of the MET signal in ALK-positive NSCLC may pave the way for further clinical trials examining MET inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247764.RACmYtj_y2LJGU4zwtuFCh_bKO2aoyK973Apte2EyuaV0130_provenance.
- NP1247764.RACmYtj_y2LJGU4zwtuFCh_bKO2aoyK973Apte2EyuaV0130_assertion evidence source_evidence_literature NP1247764.RACmYtj_y2LJGU4zwtuFCh_bKO2aoyK973Apte2EyuaV0130_provenance.
- NP1247764.RACmYtj_y2LJGU4zwtuFCh_bKO2aoyK973Apte2EyuaV0130_assertion SIO_000772 25502629 NP1247764.RACmYtj_y2LJGU4zwtuFCh_bKO2aoyK973Apte2EyuaV0130_provenance.
- NP1247764.RACmYtj_y2LJGU4zwtuFCh_bKO2aoyK973Apte2EyuaV0130_assertion wasDerivedFrom befree-2016 NP1247764.RACmYtj_y2LJGU4zwtuFCh_bKO2aoyK973Apte2EyuaV0130_provenance.
- NP1247764.RACmYtj_y2LJGU4zwtuFCh_bKO2aoyK973Apte2EyuaV0130_assertion wasGeneratedBy ECO_0000203 NP1247764.RACmYtj_y2LJGU4zwtuFCh_bKO2aoyK973Apte2EyuaV0130_provenance.